Morningstar

Bio-Rad Laboratories Inc Class A BIO

Morningstar Rating
Unlock
Stock XNYS Rating as of
$356.26 −4.93 (1.36%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
BIO is trading within a range we consider fairly valued.
Price
$356.26
Fair Value
LOCK|m>
Uncertainty
LOCK|&X
1-Star Price
LOCK|Fp
5-Star Price
%p^
Economic Moat
LOCK|c>>
Capital Allocation
LOCK|@!k#c@K

Bulls Say, Bears Say

Bulls

Bio-Rad is a leader in niche areas including quality controls, antigens, and digital PCR, and it has a strong razor-and-blade model in clinical diagnostics.

Bears

Bio-Rad’s life science business currently faces a challenging environment due to funding cuts for US life sciences research and the potential for a weakening biotech funding environment.

Show More

News

View All

Trading Information

Previous Close Price
$361.19
Day Range
$355.07–362.49
52-Week Range
$236.73–365.00
Bid/Ask
$343.33 / $369.59
Shares Outstanding
26.74M
Market Cap
$9.53B
Volume/Avg
173,819 / 356,907

Key Statistics

Price/Earnings (Normalized)
38.39
Price/Sales
3.70
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
1.41%

Company Profile

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
7,450
Website
https://www.bio-rad.com

Competitors

Valuation

View More
Metric
BIO
DHR
SRT3
Price/Earnings (Normalized)
 38.3924.9371.23
Price/Book Value
 1.332.715.81
Price/Sales
 3.705.734.59
Price/Cash Flow
 25.8420.0823.23
Price/Earnings
BIO
DHR
SRT3

Financial Strength

Metric
BIO
DHR
SRT3
Quick Ratio
 2.141.030.48
Current Ratio
 3.141.651.14
Interest Coverage
 6.3816.953.66
Quick Ratio
BIO
DHR
SRT3

Profitability

Metric
BIO
DHR
SRT3
Return on Assets (Normalized)
 2.09%5.34%3.06%
Return on Equity (Normalized)
 2.99%8.59%10.99%
Return on Invested Capital (Normalized)
 2.21%6.45%4.84%
Return on Assets
BIO
DHR
SRT3

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|nT&%@%LOCK|!#Hbl$193B
 Stryker Corp
SYK
LOCK|Z!lgFVmsLOCK|Sg&$130B
 Medtronic PLC
MDT
LOCK|l?hww&QLOCK|k@>%$117B
 Boston Scientific Corp
BSX
LOCK|%><wD%LOCK|!ZMX$75B
 Edwards Lifesciences Corp
EW
LOCK|@J<<q!gsLOCK|znq$$53B
 DexCom Inc
DXCM
LOCK|>$<@XXB?LOCK|KWfB$34B
 GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|Y@Fb<l$LOCK|H<$33B
 Koninklijke Philips NV ADR
PHG
LOCK|NnmLOCK|%<$27B
 Steris PLC
STE
LOCK|?!t>yfLOCK|YDXC$23B
 Zimmer Biomet Holdings Inc
ZBH
LOCK|<&wdDNLZLOCK|#c@$19B

Sponsor Center